HistoGenetics to Incorporate MiSeq into HLA Typing Workflow | GenomeWeb

HLA-typing firm HistoGenetics said this week that it has purchased 20 of Illumina's MiSeq systems that it will incorporate into its HLA typing workflow.

HistoGenetics' CEO Nezih Cereb told Clinical Sequencing News that the MiSeqs will initially complement the firm's 50 Life Technologies 3730xl Sanger instruments for a hybrid typing approach that will utilize the MiSeq to phase variants and provide higher resolution.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: a global genetic interaction map for Saccharomyces cerevisiae, and progress made in genomics, precision medicine, and therapeutics.

The price of plane tickets can affect how scientists in different countries choose to collaborate with each other, NPR reports.

The Annals of Improbable Research has awarded the 2016 Ig Nobel Prizes.

Scientific American alleges that the FDA has been "arm-twisting journalists into relinquishing their reportorial independence."